NeuroPace (NASDAQ:NPCE) Given New $20.00 Price Target at Cantor Fitzgerald
NeuroPace (NASDAQ:NPCE – Get Free Report) had its price objective boosted by equities research analysts at Cantor Fitzgerald from $19.00 to $20.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Cantor Fitzgerald’s target price points to a potential upside of 78.89% from the company’s current price. […]
NeuroPace (NASDAQ:NPCE – Get Free Report) had its price objective boosted by equities research analysts at Cantor Fitzgerald from $19.00 to $20.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Cantor Fitzgerald’s target price points to a potential upside of 78.89% from the company’s current price. […]
